학술논문

First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study
Document Type
Journal
Source
BREAST; DEC 2021, 60 p70-p77, 8p.
Subject
Language
English
ISSN
15323080